International Journal of Clinical Science and Medical Research

Breast cancer is a major global health burden, with alterations in gene expression contributing to tumor progression. The CDH1 gene, encoding E-cadherin, plays a critical role in maintaining epithelial integrity, and its loss has been associated with increased invasiveness and metastasis in breast cancer. This study aimed to evaluate the differential expression of CDH1 using the GSE15852 dataset. Gene expression data were obtained from the Gene Expression Omnibus (GEO) and analyzed using the GEO2R platform, comparing tumor and normal samples. Differential expression was assessed based on log fold change (logFC) and statistical significance. The analysis revealed that CDH1 is significantly downregulated in breast cancer, with a logFC of −2.386, a p-value of 2.72 × 10⁻¹¹, and an adjusted p-value of 3.68 × 10⁻¹⁴. These findings indicate a substantial and statistically significant reduction in CDH1 expression in tumor tissues. In conclusion, CDH1 is markedly downregulated in breast cancer, supporting its role as a tumor suppressor. GEO2R provides a reliable approach for preliminary gene expression analysis; however, further validation is required to confirm these findings.

Breast Cancer, CDH1, Gene Expression Analysis, GEO2R, Differential Expression

1. Abida, W., Patnaik, A., Campbell, D., Shapiro, J., Bryce, A. H., McDermott, R., Sautois, B., Vogelzang, N. J., Bambury, R. M., Voog, E., Zhang, J., Piulats, J. M., Ryan, C. J., Merseburger, A. S., Daugaard, G., Heidenreich, A., Fizazi, K., Higano, C. S., Krieger, L. E., … Chowdhury, S. (2020). Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration. Journal of Clinical Oncology, 38(32), 3763–3772. https://doi.org/10.1200/JCO.20.01035
2. Albert, C., Haase, M., Albert, A., Kropf, S., Bellomo, R., Westphal, S., Westerman, M., Braun-Dullaeus, R. C., & Haase-Fielitz, A. (2020). Urinary Biomarkers may Complement the Cleveland Score for Prediction of Adverse Kidney Events After Cardiac Surgery: A Pilot Study. Annals of Laboratory Medicine, 40(2), 131–141. https://doi.org/10.3343/alm.2020.40.2.131
3. Algebaly, A. S., Suliman, R. S., & Al-Qahtani, W. S. (2021). Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer. Clinical and Translational Oncology, 23(1), 74–81. https://doi.org/10.1007/s12094-020-02385-9
4. Cheng, H. H., Shevach, J. W., Castro, E., Couch, F. J., Domchek, S. M., Eeles, R. A., Giri, V. N., Hall, M. J., King, M.-C., Lin, D. W., Loeb, S., Morgan, T. M., Offit, K., Pritchard, C. C., Schaeffer, E. M., Szymaniak, B. M., Vassy, J. L., Katona, B. W., & Maxwell, K. N. (2024). BRCA1, BRCA2 , and Associated Cancer Risks and Management for Male Patients. JAMA Oncology, 10(9), 1272. https://doi.org/10.1001/jamaoncol.2024.2185
5. de Jonge, M. M., de Kroon, C. D., Jenner, D. J., Oosting, J., de Hullu, J. A., Mourits, M. J. E., Gómez Garcia, E. B., Ausems, M. G. E. M., Margriet Collée, J., van Engelen, K., van de Beek, I., Smit, V. T. H. B. M., Rookus, M. A., de Bock, G. H., van Leeuwen, F. E., Bosse, T., Dekkers, O. M., & van Asperen, C. J. (2021). Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study. JNCI: Journal of the National Cancer Institute, 113(9), 1203–1211. https://doi.org/10.1093/jnci/djab036
6. Dines, J. N., Shirts, B. H., Slavin, T. P., Walsh, T., King, M.-C., Fowler, D. M., & Pritchard, C. C. (2020). Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots.” Genetics in Medicine, 22(5), 825–830. https://doi.org/10.1038/s41436-019-0740-6
7. Gruber, J. J., Afghahi, A., Timms, K., DeWees, A., Gross, W., Aushev, V. N., Wu, H.-T., Balcioglu, M., Sethi, H., Scott, D., Foran, J., McMillan, A., Ford, J. M., & Telli, M. L. (2022). A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. Nature Cancer, 3(10), 1181–1191. https://doi.org/10.1038/s43018-022-00439-1
8. Kotsopoulos, J., Gronwald, J., Huzarski, T., Møller, P., Pal, T., McCuaig, J. M., Singer, C. F., Karlan, B. Y., Aeilts, A., Eng, C., Eisen, A., Bordeleau, L., Foulkes, W. D., Tung, N., Couch, F. J., Fruscio, R., Neuhausen, S. L., Zakalik, D., Cybulski, C., … Rastelli, A. (2024). Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. JAMA Oncology, 10(4), 484. https://doi.org/10.1001/jamaoncol.2023.6937
9. Lee, Y.-C., Lee, Y.-C., Li, C.-Y., Lee, Y.-L., & Chen, B.-L. (2020). BRCA1 and BRCA2 Gene Mutations and Lung Cancer Risk: A Meta-Analysis. Medicina, 56(5), 212. https://doi.org/10.3390/medicina56050212
10. Lubinski, J., Kotsopoulos, J., Moller, P., Pal, T., Eisen, A., Peck, L., Karlan, B. Y., Aeilts, A., Eng, C., Bordeleau, L., Foulkes, W. D., Tung, N., Couch, F. J., Fruscio, R., Ramon y Cajal, T., Singer, C. F., Neuhausen, S. L., Zakalik, D., Cybulski, C., … Blum, J. (2024). MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. JAMA Oncology, 10(4), 493. https://doi.org/10.1001/jamaoncol.2023.6944
11. Markowski, M. C., & Antonarakis, E. S. (2020). BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 38(32), 3735–3739. https://doi.org/10.1200/JCO.20.02246
12. Narod, S. A., Metcalfe, K., Finch, A., Chan, A.-W., Armel, S. R., Aeilts, A., Eisen, A., Karlan, B., Bordeleau, L., Tung, N., Foulkes, W. D., Neuhausen, S. L., Eng, C., Olopade, O., Zakalik, D., Couch, F., Cullinane, C., Pal, T., Sun, P., … Cohen, S. (2024). The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations. Hereditary Cancer in Clinical Practice, 22(1), 7. https://doi.org/10.1186/s13053-024-00277-5
13. Sadeghi, F., Asgari, M., Matloubi, M., Ranjbar, M., Karkhaneh Yousefi, N., Azari, T., & Zaki-Dizaji, M. (2020). Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biological Procedures Online, 22(1), 23. https://doi.org/10.1186/s12575-020-00133-5
14. Silvestri, V., Leslie, G., Barnes, D. R., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Barkardottir, R. B., Barroso, A., Barrowdale, D., Benitez, J., Bonanni, B., Borg, A., Buys, S. S., Caldés, T., Caligo, M. A., Capalbo, C., Campbell, I., Chung, W. K., … Ottini, L. (2020). Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncology, 6(8), 1218. https://doi.org/10.1001/jamaoncol.2020.2134
15. Song, Y., Barry, W. T., Seah, D. S., Tung, N. M., Garber, J. E., & Lin, N. U. (2020). Patterns of recurrence and metastasis in BRCA1/BRCA2 ‐associated breast cancers. Cancer, 126(2), 271–280. https://doi.org/10.1002/cncr.32540